Literature DB >> 10575133

Viruses, cancer and AIDS.

R A Weiss1.   

Abstract

Patients with AIDS are at risk of lymphoma and Kaposi's sarcoma. These tumours are associated with the gamma herpesviruses, Epstein-Barr virus (EBV) and human herpesvirus 8 (HHV-8), although a proportion of AIDS lymphomas lacks both viruses. EBV and HHV-8 are latent in the tumour cells, with genes that play a direct role in driving cell proliferation. Human immunodeficiency virus, in contrast, while being the greatest risk factor for lymphoma and Kaposi's sarcoma, acts indirectly, mainly by causing immune suppression, as immunosuppressed transplant patients are at risk for the same types of tumour.

Entities:  

Mesh:

Year:  1999        PMID: 10575133     DOI: 10.1111/j.1574-695X.1999.tb01393.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  4 in total

1.  The association of neoplasms and HIV infection in the correctional setting.

Authors:  Jacques Baillargeon; Brad H Pollock; Charles T Leach; Shou-Jiang Gao
Journal:  Int J STD AIDS       Date:  2004-05       Impact factor: 1.359

2.  Peritumoral inflammatory infiltrate is not a prognostic factor in distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Rodrigo O Perez; Angelita Habr-Gama; Rafael Miyashiro Nunes dos Santos; Igor Proscurshim; Fábio G Campos; Viviane Rawet; Desiderio Kiss; Ivan Cecconello
Journal:  J Gastrointest Surg       Date:  2007-09-01       Impact factor: 3.452

3.  Differential gene expression in HIV/SIV-associated and spontaneous lymphomas.

Authors:  V V Nenasheva; A I Nikolaev; A V Martynenko; I B Kaplanskaya; W Bodemer; G Hunsmann; V Z Tarantul
Journal:  Int J Med Sci       Date:  2005-10-01       Impact factor: 3.738

4.  Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.

Authors:  Connie G Chiu; Danielle Smith; Kate A Salters; Wendy Zhang; Steve Kanters; David Milan; Julio S G Montaner; Andy Coldman; Robert S Hogg; Sam M Wiseman
Journal:  BMC Cancer       Date:  2017-04-14       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.